A Geospatial Model to Identify Areas Associated with Late- Stage Breast Cancer: A Spatial Epidemiology Approach

Reyna-Sevilla, Antonio; Gonzalez-Castañeda, Miguel Ernesto; Ramos-Herrera, Igor Martin; Duque-Molina, Celida; Borrayo-Sanchez, Gabriela; Aviles-Hernandez, Ricardo; Quezada-Sanchez, Carlos; Flores-Morales, Abelardo

doi:10.31557/APJCP.2023.24.8.2621

A Geospatial Model to Identify Areas Associated with Late- Stage Breast Cancer: A Spatial Epidemiology Approach

Document Type : Research Articles

Authors

¹ Health Planning and Innovation Unit, Directorate of Medical Benefits, Mexican Social Security Institute, Cuauhtémoc, CDMX, Mexico.

² Department of Public Health, University Center for Health Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico.

³ Directorate of Medical Benefits, Mexican Social Security Institute, Cuauhtémoc, CDMX, Mexico.

⁴ Health Innovation Coordination, Health Planning and Innovation Unit, Medical Benefits Directorate, Mexican Social Security Institute, Cuauhtémoc, CDMX, Mexico.

⁵ Health Planning and Innovation Unit, Directorate of Medical Benefits, Mexican Institute of Social Security, Cuauhtémoc, CDMX, Mexico.

10.31557/APJCP.2023.24.8.2621

Abstract

Objective: The aim of this study was to show how a geospatial model can be used to identify areas with a higher probability for late-stage breast cancer (BC) diagnoses. Methods: Our study considered an ecological design. Clinical records at a tertiary care hospital were reviewed in order to obtain the place of residence and stage of the disease, which was classified as early (0-IIA) and late (IIB-IV) and whose diagnoses were made during the 2013-2017 period. Then, they were geolocated to identify the distribution and spatial trend. Subsequently, the pattern of location, i.e. scattered, random and concentrated, was statistically assessed and a geospatial model was elaborated to determine the probability of late diagnoses in the state of Jalisco, Mexico. Result: There were 1 954 (N) geolocated BC diagnoses: 58.3% were late. During the five-year period, a southwest-northeast trend was identified, nearly 9.5% of the surface of Jalisco, where 6 out of 10 (n= 751) late- stage diagnoses were concentrated. A concentrated and statistically significant pattern was identified in the southern, central and northern Pacific area of Jalisco, where the geospatial model delimited the places with the highest probability of late clinical stages (p <0.05). Conclusion: The geographical differences associated with the late diagnoses of BC suggest it is necessary to adapt and focus the strategies for early detection as an alternative to create a major impact on the population. Reproducible analysis tools were used in other contexts where geolocation data are available to complement public policies and strategies aimed to control BC.

Keywords

Main Subjects